Cargando…
Long-term drug effectiveness and survival for reference rituximab in rheumatoid arthritis patients in an ordinary outpatient clinic
To explore the long-term drug effectiveness and survival of reference rituximab (ref-RTX)-treated rheumatoid arthritis (RA) patients in an ordinary outpatient clinic. Second, we explored baseline predictors of drug effectiveness and survival, and third, we clarified reasons for stopping treatment. R...
Autores principales: | Łosińska, Katarzyna, Wilk, Mateusz, Pripp, Are Hugo, Korkosz, Mariusz, Haugeberg, Glenn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117312/ https://www.ncbi.nlm.nih.gov/pubmed/35585215 http://dx.doi.org/10.1038/s41598-022-12271-9 |
Ejemplares similares
-
Real-world experience of rituximab biosimilar GP2013 in rheumatoid arthritis patients naïve to or switched from reference rituximab
por: Łosińska, Katarzyna, et al.
Publicado: (2023) -
Remission or Not Remission, That’s the Question: Shedding Light on Remission and the Impact of Objective and Subjective Measures Reflecting Disease Activity in Rheumatoid Arthritis
por: Brkic, Alen, et al.
Publicado: (2022) -
No deterioration in health-related quality of life in patients with axial spondyloarthritis followed for 5 years in ordinary outpatient clinics in the biological treatment era
por: Rohde, Gudrun, et al.
Publicado: (2019) -
Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway
por: Haugeberg, Glenn, et al.
Publicado: (2015) -
Endothelial dysfunction in patients with ankylosing spondylitis
por: Łosińska, Katarzyna, et al.
Publicado: (2019)